|
|
Ron Rowland: Like many of you, I’m a Baby Boomer. Now I find myself north of 50 and the prospect of getting “old” isn’t very attractive. What does this have to do with investing and ETFs? Plenty! Read more…
IBB, NASDAQ:BIB, NASDAQ:BIS, NYSE:FBT, PBE, XBI
ProShares, the leading manager of leveraged and inverse ETFs, announced today that it is launching the first ETFs with leveraged and inverse exposure to the biotechnology sector. The ETFs seek to provide 200% or -200% of the return of the NASDAQ Biotechnology Index® for a single day. Read more…
ProShares has filed paperwork with the SEC for an UltraShort Nasdaq Biotechnology ETF. There is no symbol noted at this time. The ProShares UltraShort Nasdaq Biotechnology (the “Fund”) will Read more…
Most Comments